Hepatic neoplasia

The clinicopathologic features of hepatic neoplasms such as hepatocellular adenomas, hepatocellular carcinomas, bile duct carcinomas, and hepatic carcinoids are presented. The authors also discuss the diagnostic and therapeutic approaches to hepatic neoplasia.     

Fascioloides magna: Occurrence in Saskatchewan and Distribution in Canada

Infection with Fascioloides magna, the large American liver fluke, was diagnosed in two moose (Alces alces) and six wapiti (Cervus elaphus) from central Saskatchewan. This is believed to be the first record of the parasite in the province. Fecal samples collected from wild wapiti at five sites in the commercial forest zone in Saskatchewan contained eggs believed to be those of F. magna. Trematode eggs were not found in feces from five captive herds of wapiti in the province, nor in samples from wild wapiti in Moose Mountain Provincial Park. Operculate eggs were found in feces of wild wapiti from Cypress Hills, but these were believed to be from trematodes other than F. magna. The distribution and significance of F. magna in Canada, based partially on responses to a mail questionnaire, are reviewed.     

The longevity of immunoglobulin preservation in canine skin utilizing Michel's fixative

Skin biopsy specimens from 7 dogs with immune-mediated skin diseases diagnosed by routine histology and 5 dogs with other skin diseases were placed in Michel's transport medium for 4 to 9 years. Direct immunofluorescence yielded positive results in tissue samples from 3 dogs with pemphigus foliaceus and 2 dogs with discoid lupus erythematosus. Direct immunofluorescence was not seen in tissue samples from 1 dog with pemphigus foliaceus and 5 dogs with non immune-mediated skin diseases. Direct immunofluorescence was seen in skin biopsy specimens maintained in Michel's medium for 4 to 8 years.     

Changes in liveweight and behaviour of alpaca dams and offspring following weaning

The effects of offspring sex, weight, age, and level of interaction with the dam on responses to weaning were examined to assist in the development of a weaning protocol for alpacas. In the first study, preand post-weaning activities, and weight change over Days -12-0,0-7 and 7-16 with respect to weaning, were recorded for 20 dam-offspring (hembra-cria) pairs aged 81-200 days. Pre-weaning changes in dam and offspring weights were positively related (P<0.05). Although heavier crias tended to be found closer to their dams than lighter crias (P<0.05) no additional effect of age on the dam-offspring relationship was found. Following weaning, cria growth rates were low over Days 0-7 but improved over Days 7-16, and hembra weight change followed the same pattern. Over Days 0-2, grazing and sitting activities of hembras and crias were replaced by standing and walking along paddock fencelines, although by Day 2 fenceline activities had decreased (P<0.05). Crias which were more frequently observed at fencelines had lower post-weaning growth rates (P<0.05). In the second study, pre-weaning sucking behaviour, and weight change over Days -30-0, 0-8 and 8-16 with respect to weaning, were recorded for 19 hembra-cria pairs aged 124-160 days. During 10 hours of observation on Days -5 and -4, the total duration of sucking by individual crias varied from 0-18 minutes, and the mean +/- SEM duration of sucking was 1.94 +/- 0.113 minutes. Cria sucking behaviour was positively related to growth rate prior to and weight at weaning (P<0.05). As in the first study, pre-weaning changes in dam and offspring weights were positively related (P<0.05). Following weaning, growth rates of the crias were depressed and the hembras lost weight over Days 0-8 and 8-16. The changes in growth rate and behaviour in Studies 1 and 2 indicated that weaning can be stressful for hembras and crias. However, there was no evidence from either study that pre-weaning behavioural or physical characteristics were related to the changes.     

Influence of yohimbine and tolazoline on the cardiovascular, respiratory, and sedative effects of xylazine in the horse

To determine the effects of yohimbine and tolazoline on the cardiovascular, respiratory and sedative effects of xylazine, four horses were sedated with xylazine and treated with either yohimbine, tolazoline or saline. Xylazine was administered as an intravenous (i.v.) bolus (1.0 nig/kg) followed by a continuous infusion at the rate of 12 μg/kg/min. Heart rate, respiratory rate, mean arterial pressure, arterial blood gases, and the chin-to-floor distance were recorded throughout the experiment. After 60 min, either yohimbine or tolazoline was administered i.v. in incremental doses until reversal of sedation (defined as the return of the chin-to-floor distance to baseline values) was achieved. A control group in which a saline bolus was administered instead of an antagonist drug was included for comparison.
The average dose of yohimbine administered was 0.12 ± 0.02 (SEM) mg/kg. While the average dose of tolazoline was 7.5 ± 1.1 mg/kg. Both tolazoline and yohimbine antagonized the ventricular bradycardia and A-V conduction disturbances observed with xylazine administration. No change in mean arterial pressure was observed with xylazine or yohimbine administration, but tolazoline caused persistent mild systemic hypertension. There were no clinically significant changes in respiratory rate or arterial blood gas values with administration of either xylazine, yohimbine or tolazoline. The chin-to-floor distance decreased significantly with xylazine administration and increased significantly with administration of either yohimbine or tolazoline. In conclusion, both yohimbine and tolazoline successfully antagonized the cardiovascular and CNS depression associated with xylazine administration.     

Controlled Tissue Expansion in the Distal Extremities of Dogs

Controlled tissue expansion using a 100 cc rectangular silicone elastomer expander was performed in the mid-antebrachium and mid-crus of eight adult mixed-breed dogs. Two expander inflation schedules were followed. Group 1 dogs (n = 4) underwent expander inflation using 10 cc sterile saline every other day, and group 2 dogs (n = 4) underwent expander inflation using 15 cc sterile saline every other day until the nominal volume (100 cc) was attained. Significant mean postexpansion increases in skin surface area of 94.1 cm² (35.9%) and 108.9 cm² (37.3%) were measured in the antebrachium and crus, respectively (p < .05). In a second procedure, the expanders were removed and skin flaps were developed from the redundant tissue generated during the expansion process. Single pedicle advancement flaps and transposition flaps were used to cover surgically created defects measuring 5 times 10 cm in the antebrachium and cms. Single pedicle advancement flaps consistently measured 10 × 10 cm and could be advanced to cover defects involving one third of the mid-antebrachial or mid-crural circumference. Transposition flaps were rotated up to 170 and the donor site defects were easily closed under minimal or no tension. Complications included an abscess in one dog and seroma formation in four dogs. Differences in success or complication rates between group 1 dogs and group 2 dogs were not observed; an accelerated inflation schedule using 15 cc sterile saline every other day was recommended.     

Surgical technique to cannulate the rete testis of the goat

A surgical technique was devised to collect rete testis fluid from 14 mature goats. The tubular portion of the extratesticular rete testis was cannulated where it penetrated the tunica albuginea of the testis under the center of the head of the epididymis. The tip of the cannula was sutured in place in the extratesticular rete testis and the opposite end was passed through the scrotum and into a plastic collection bottle. The bottle was glued to pillow ticking, which was sutured to the scrotum. Continuous flow of rete testis fluid occurred for 0 to 14 days and was usually terminated by a sperm clot in the cannula. The flow rate was 0.59 +/- 0.37 ml/hr.